Case report: Successful treatment of relapsing polychondritis and crohn’s disease with tocilizumab
Moy LN, Brandwein SR. Case Report: Successful Treatment of Relapsing Polychondritis and Crohn’s Disease with Tocilizumab. SN Comprehensive Clinical Medicine. 2022/10/13 2022;4(1):226. doi:10.1007/s42399-022-01310-1
Relapsing polychondritis is a rare autoimmune inflammatory syndrome with no established treatment guidelines or placebo-controlled clinical trials. Most treatment plans are based on anecdotal case reports. We present a case of refractory relapsing polychondritis in a patient with Crohn’s disease. She has responded well and has achieved clinical remission on treatment with interleukin-6 receptor inhibitor tocilizumab.